Organization
Synermore Biologics
2 clinical trials
Clinical trial
A Phase 2b Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults With Different Rabies Exposure RisksStatus: Completed, Estimated PCD: 2021-12-23
Clinical trial
A Phase 1 Dose Escalation Trial of SYN125 Single Agent in Solid Tumors and in Combination With Fixed Dose SYN004 in Patients With Epithelial Cancers With EGFR Expressions.Status: Active (not recruiting), Estimated PCD: 2023-07-31